Background illustration for clinical trials search

Paid Clinical Trials Sandy Springs

Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Venetoclax Basket Trial for High Risk Hematologic Malignancies

for
Myelodysplastic Syndromes, de Novo,
Location: Atlanta GA, Chicago IL, Boston MA, Aurora CO,
Sponsor: Andrew E. Place, MD

Sex: All

Age: 1 - 40

Code: NCT05292664

Phase 1, Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for
Wilms Tumor, Rhabdoid Tumor,
Location: Atlanta GA, Cincinnati OH, St Louis MO,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT05985161

Phase 2, Recruiting

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

for
COVID-19
Location: Atlanta GA, Shreveport LA, Chicago IL, Miami FL,
Sponsor: Pfizer

Sex: All

Age: 0 - 17

Code: NCT05261139

Phase 3, Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Atlanta GA, Memphis TN, Cincinnati OH, Columbus OH,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase 1, Phase 2, Recruiting

A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis

for
Cystic Fibrosis
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 12 - 21

Code: NCT06350149

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Atlanta GA, Columbus GA, Greenville SC, Columbia SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase 3, Recruiting

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

for
Sickle Cell Disease
Location: Atlanta GA, Greenville SC, Travelers Rest SC,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT05431088

Phase 2, Phase 3, Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for
Type 1 Diabetes
Location: Atlanta GA, Asheville NC, Gainesville FL,
Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase 2, Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Atlanta GA, Nashville TN, Chapel Hill NC, Cincinnati OH,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase 2, Recruiting

Caregiver as Navigator: Develop Skills Online (CAN-DO)

for
Dementia
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06177990

Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Atlanta GA, Birmingham AL, Memphis TN, Cincinnati OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase 1, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Atlanta GA, Greenville SC, Knoxville TN, Columbia SC,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase 2, Recruiting

Treatment of Hemophilia A Patients With FVIII Inhibitors

for
Hemophilia A
Location: Atlanta GA
Sponsor: Emory University

Sex: Male

Age: 0+

Code: NCT04023019

Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Atlanta GA, Birmingham AL, Memphis TN, Cincinnati OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase 1, Phase 2, Recruiting

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

for
Hemorrhagic Shock, Trauma Injury
Location: Atlanta GA, Wake Forest NC, Memphis TN, Jackson MS,
Sponsor: Philip Spinella

Sex: All

Age: 0 - 17

Code: NCT06070350

Phase 3, Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

for
Cardiovascular Disorder, Classic Hodgkin Lymphoma,
Location: Atlanta GA, Knoxville TN, Winston-Salem NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 7+

Code: NCT05705531

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Atlanta GA, Nashville TN, Charlotte NC, Durham NC,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase 3, Recruiting

HFNC vs NIPPV Following Extubation

for
Congenital Heart Disease
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0 - 1

Code: NCT05869825

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Atlanta GA, Macon GA, Chattanooga TN, Greenville SC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

for
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma,
Location: Atlanta GA, Birmingham AL, Memphis TN, Durham NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 18

Code: NCT05504291

Phase 2, Recruiting